Axo Longevity

Optimised Biomarker Driven Preventive Health

Menlo Park, United States · $5.0M raised

Business Model
B2C
Total Funding
$5.0M
Last Round
$5.0M SeedSep 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Axo Longevity is a biomarker-driven preventive health platform operating across Europe that combines 100+ lab tests with expert analysis and personalised health blueprints. Founded by former Red Bull Head of High Performance Andy Walshe PhD and CMO Dr. Niko Mihic MD, the platform measures key biomarkers across cardiovascular, hormonal, metabolic, and immune systems to produce an Axo Health Score and Biological Age calculation. Members receive a personalised action plan covering nutrition, sleep, supplementation, exercise, and stress, with follow-up retesting at six months to track progress.

Summary

Axo Longevity is a Biotech company based in Menlo Park, United States. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Sep 2026.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSep 2026
$5.0M

Similar Companies

Hims and HersIPO

Telehealth platform providing personalized health and wellness treatments for men and women, cove...

San Francisco, United States501–1000Digital Health, E-Commerce
ConvertibleTotal funding$2.6BJan 2026
Whoop

Fitness wearable company offering a subscription-based health tracker that measures strain, recov...

Boston, United States501–1000Digital Health, Healthcare
Series G+Total funding$969.4MMar 2026
Noom

Noom delivers psychology-based weight management programs that combine daily lessons, personalize...

New York, United States1001–5000Digital Health, Healthcare
Series FTotal funding$652.2MMay 2021
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Axo Longevity on Indexed.vc
<a href="https://indexed.vc/companies/axo-longevity"><img src="https://indexed.vc/api/badge/company/axo-longevity" alt="Axo Longevity on Indexed.vc" width="260" height="76" /></a>